Membrane Lipids and CFTR: The Yin/Yang of Efficient Ceramide Metabolism
- PMID: 32687399
- PMCID: PMC7560806
- DOI: 10.1164/rccm.202006-2362ED
Membrane Lipids and CFTR: The Yin/Yang of Efficient Ceramide Metabolism
Comment on
-
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.Am J Respir Crit Care Med. 2020 Oct 15;202(8):1133-1145. doi: 10.1164/rccm.202001-0180OC. Am J Respir Crit Care Med. 2020. PMID: 32569477 Free PMC article.
References
-
- Chen Y, Cao Y. The sphingomyelin synthase family: proteins, diseases, and inhibitors. Biol Chem. 2017;398:1319–1325. - PubMed
-
- Ventura AE, Mestre B, Silva LC. Ceramide domains in health and disease: a biophysical perspective. Adv Exp Med Biol. 2019;1159:79–108. - PubMed
-
- Garić D, De Sanctis JB, Shah J, Dumut DC, Radzioch D. Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: the importance of side chain. Prog Lipid Res. 2019;74:130–144. - PubMed
-
- Yang Y, Uhlig S. The role of sphingolipids in respiratory disease. Ther Adv Respir Dis. 2011;5:325–344. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
